BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 33767215)

  • 1. The difficulty to model Huntington's disease in vitro using striatal medium spiny neurons differentiated from human induced pluripotent stem cells.
    Le Cann K; Foerster A; Rösseler C; Erickson A; Hautvast P; Giesselmann S; Pensold D; Kurth I; Rothermel M; Mattis VB; Zimmer-Bensch G; von Hörsten S; Denecke B; Clarner T; Meents J; Lampert A
    Sci Rep; 2021 Mar; 11(1):6934. PubMed ID: 33767215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manifestation of Huntington's disease pathology in human induced pluripotent stem cell-derived neurons.
    Nekrasov ED; Vigont VA; Klyushnikov SA; Lebedeva OS; Vassina EM; Bogomazova AN; Chestkov IV; Semashko TA; Kiseleva E; Suldina LA; Bobrovsky PA; Zimina OA; Ryazantseva MA; Skopin AY; Illarioshkin SN; Kaznacheyeva EV; Lagarkova MA; Kiselev SL
    Mol Neurodegener; 2016 Apr; 11():27. PubMed ID: 27080129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GABAergic neurons from mouse embryonic stem cells possess functional properties of striatal neurons in vitro, and develop into striatal neurons in vivo in a mouse model of Huntington's disease.
    Shin E; Palmer MJ; Li M; Fricker RA
    Stem Cell Rev Rep; 2012 Jun; 8(2):513-31. PubMed ID: 21720791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease.
    Zhang H; Li Q; Graham RK; Slow E; Hayden MR; Bezprozvanny I
    Neurobiol Dis; 2008 Jul; 31(1):80-8. PubMed ID: 18502655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling Huntington׳s disease with patient-derived neurons.
    Mattis VB; Svendsen CN
    Brain Res; 2017 Feb; 1656():76-87. PubMed ID: 26459990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges in progressing cell therapies to the clinic for Huntington's disease: A review of the progress made with pluripotent stem cell derived medium spiny neurons.
    Garcia Jareño P; Bartley OJM; Precious SV; Rosser AE; Lelos MJ
    Int Rev Neurobiol; 2022; 166():1-48. PubMed ID: 36424090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Striatal Direct and Indirect Pathway Output Structures Are Differentially Altered in Mouse Models of Huntington's Disease.
    Barry J; Akopian G; Cepeda C; Levine MS
    J Neurosci; 2018 May; 38(20):4678-4694. PubMed ID: 29691329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitigation of augmented extrasynaptic NMDAR signaling and apoptosis in cortico-striatal co-cultures from Huntington's disease mice.
    Milnerwood AJ; Kaufman AM; Sepers MD; Gladding CM; Zhang L; Wang L; Fan J; Coquinco A; Qiao JY; Lee H; Wang YT; Cynader M; Raymond LA
    Neurobiol Dis; 2012 Oct; 48(1):40-51. PubMed ID: 22668780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synaptic scaling up in medium spiny neurons of aged BACHD mice: A slow-progression model of Huntington's disease.
    Rocher AB; Gubellini P; Merienne N; Boussicault L; Petit F; Gipchtein P; Jan C; Hantraye P; Brouillet E; Bonvento G
    Neurobiol Dis; 2016 Feb; 86():131-9. PubMed ID: 26626081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular Models: HD Patient-Derived Pluripotent Stem Cells.
    Geater C; Hernandez S; Thompson L; Mattis VB
    Methods Mol Biol; 2018; 1780():41-73. PubMed ID: 29856014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington's disease patient cells.
    Juopperi TA; Kim WR; Chiang CH; Yu H; Margolis RL; Ross CA; Ming GL; Song H
    Mol Brain; 2012 May; 5():17. PubMed ID: 22613578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulation of Neuronal Calcium Signaling via Store-Operated Channels in Huntington's Disease.
    Czeredys M
    Front Cell Dev Biol; 2020; 8():611735. PubMed ID: 33425919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and functional features of medium spiny neurons in the BACHDΔN17 mouse model of Huntington's Disease.
    Goodliffe J; Rubakovic A; Chang W; Pathak D; Luebke J
    PLoS One; 2020; 15(6):e0234394. PubMed ID: 32574176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Components of Store-Operated Calcium Channels in the Regulation of Neural Stem Cell Physiology, Neurogenesis, and the Pathology of Huntington's Disease.
    Latoszek E; Czeredys M
    Front Cell Dev Biol; 2021; 9():657337. PubMed ID: 33869222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic Analysis of Huntington's Disease Medium Spiny Neurons Identifies Alterations in Lipid Droplets.
    Tshilenge KT; Aguirre CG; Bons J; Gerencser AA; Basisty N; Song S; Rose J; Lopez-Ramirez A; Naphade S; Loureiro A; Battistoni E; Milani M; Wehrfritz C; Holtz A; Hetz C; Mooney SD; Schilling B; Ellerby LM
    Mol Cell Proteomics; 2023 May; 22(5):100534. PubMed ID: 36958627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional and Molecular Properties of DYT-SGCE Myoclonus-Dystonia Patient-Derived Striatal Medium Spiny Neurons.
    Kutschenko A; Staege S; Grütz K; Glaß H; Kalmbach N; Gschwendtberger T; Henkel LM; Heine J; Grünewald A; Hermann A; Seibler P; Wegner F
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cell therapy and cellular engineering for treatment of neuronal dysfunction in Huntington's disease.
    Choi KA; Hwang I; Park HS; Oh SI; Kang S; Hong S
    Biotechnol J; 2014 Jul; 9(7):882-94. PubMed ID: 24827816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys.
    Cho IK; Yang B; Forest C; Qian L; Chan AWS
    PLoS One; 2019; 14(3):e0214156. PubMed ID: 30897183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neocortical expression of mutant huntingtin is not required for alterations in striatal gene expression or motor dysfunction in a transgenic mouse.
    Brown TB; Bogush AI; Ehrlich ME
    Hum Mol Genet; 2008 Oct; 17(20):3095-104. PubMed ID: 18632688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced Store-Operated Calcium Entry Leads to Striatal Synaptic Loss in a Huntington's Disease Mouse Model.
    Wu J; Ryskamp DA; Liang X; Egorova P; Zakharova O; Hung G; Bezprozvanny I
    J Neurosci; 2016 Jan; 36(1):125-41. PubMed ID: 26740655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.